InvestLog
ESPR Esperion Therapeutics, Inc. logo

ESPR Esperion Therapeutics, Inc.

Healthcare
$3.13+0.00%OpenMarket Cap: $650.8M

As of 2026-05-26

Insider Statistics (Q1 2026)

Acquisitions

6

Dispositions

4

Buy/Sell Ratio

1.50

Net Shares

+2,370,591

Shares Acquired

2,409,990

Shares Disposed

39,399

Total Bought ($)

$0.00

Total Sold ($)

$4.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Wed Mar 18Looker Benjaminofficer: Chief Legal OfficerSell5,708$2.70679,348
Wed Mar 18Koenig Sheldon L.director, officer: President and CEOSell25,578$2.722,172,699
Wed Mar 18Halladay Benjaminofficer: Chief Financial OfficerSell6,424$2.71713,602
Mon Mar 16Looker Benjaminofficer: Chief Legal OfficerSell300,840$0.00685,056
Mon Mar 16Looker Benjaminofficer: Chief Legal OfficerSell269,230$2.44269,230
Mon Mar 16Koenig Sheldon L.director, officer: President and CEOSell723,760$0.002,198,277
Mon Mar 16Koenig Sheldon L.director, officer: President and CEOSell647,460$2.44647,460
Mon Mar 16Halladay Benjaminofficer: Chief Financial OfficerSell247,430$0.00720,026
Mon Mar 16Halladay Benjaminofficer: Chief Financial OfficerSell221,270$2.44221,270
Wed Jan 21Looker Benjaminofficer: General CounselSell1,689$2.88384,216